Natural history of portal vein thrombosis in cirrhosis: A systematic review with meta‐analysis
- 24 June 2023
- journal article
- review article
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 38 (10) , 1710-1717
Abstract
Background and Aim: Progression of liver disease in cirrhosis is associated with an increased incidence of portal vein thrombosis (PVT) in cirrhosis. However, evidence suggests that spontaneous recanalization of PVT may occur even without anti‐thrombotic therapy. Thus, the present meta‐analysis was conducted to study the natural history of PVT in cirrhosis, facilitating decisions regarding anticoagulation.Methods: Three electronic databases were searched from 2000 to August 2022 for studies reporting the outcome of PVT in cirrhotics without anticoagulation. The pooled proportions with their 95% confidence intervals (CIs) were calculated using a random‐effect model.Results: A total of 26 studies (n = 1441) were included in the final analysis. Progression of PVT on follow‐up was seen in 22.2% (95% CI 16.1–28.4), while 77.7% (95% CI 71.6–83.9) remained non‐progressive (improved or stable). The most common outcome was a stable PVT with a pooled event rate of 44.6% (95% CI 34.4–54.7). The pooled rates of regression and complete recanalization of PVT in cirrhotics were 29.3% (95% CI 20.9–37.7) and 10.4% (95% CI 5.0–15.8), respectively. On follow‐up after improvement, pooled recurrence rate of PVT was 24.0% (95% CI 14.7–33.4). MELD score, and presence of ascites had a negative association, while a longer follow‐up duration had positive association with PVT regression.Conclusion: Approximately 25% of the cases of PVT in cirrhosis are progressive, 30% cases improve, and 45% remain stable. Future studies are needed to analyze the predictors of spontaneous regression.Keywords
This publication has 34 references indexed in Scilit:
- EASL Clinical Practice Guidelines: Vascular diseases of the liverJournal of Hepatology, 2016
- Efficacy and safety of anticoagulation in more advanced portal vein thrombosis in patients with liver cirrhosisEuropean Journal of Gastroenterology & Hepatology, 2016
- Causes and consequences of portal vein thrombosis in 1,243 patients with cirrhosis: Results of a longitudinal studyHepatology, 2015
- Safety, efficacy, and response predictors of anticoagulation for the treatment of nonmalignant portal-vein thrombosis in patients with cirrhosis: a propensity score matching analysisClinical and Molecular Hepatology, 2014
- Natural course of nonmalignant partial portal vein thrombosis in cirrhotic patientsSaudi Journal of Gastroenterology, 2014
- Natural Course of Extrahepatic Nonmalignant Partial Portal Vein Thrombosis in Patients with CirrhosisRadiology, 2012
- Prospective evaluation of anticoagulation and transjugular intrahepatic portosistemic shunt for the management of portal vein thrombosis in cirrhosisLiver International, 2012
- Thrombotic risk factors in patients with liver cirrhosis: Correlation with MELD scoring system and portal vein thrombosis developmentJournal of Hepatology, 2009
- Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulationGut, 2005
- Meta-analysis of Observational Studies in EpidemiologyA Proposal for ReportingJAMA, 2000